Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Psychiatric co-morbidity among women with substance use disorders

Psychiatric co-morbidity among women with substance use disorders Guest editorial Alexandra Garcia-Guix, Juan Ignacio Mestre-Pinto, Judit Tirado-Muñoz, Antonia Domingo-Salvany and Marta Torrens Alexandra Garcia-Guix is based at the Hospital del Mar Medical Epidemiological and clinical studies have described a high co-occurrence of substance use Research Institute – IMIM, disorders (SUD) and other psychiatric disorders, known as “dual diagnosis” (Torrens et al., n.d.; Barcelona, Spain; and Institut de Kingston et al., 2017). These patients with a dual diagnosis are reported to have more Neuropsiquiatria i addiccions – INAD, Barcelona, Spain. emergency admissions, higher prevalence of suicide, increased rates of medical co-morbidity, Juan Ignacio Mestre-Pinto is more risk of relapse in drug use and psychiatric disorder, higher unemployment and based at the Hospital del Mar homelessness rates and greater incident of violent or criminal behaviour (Greenberg and Medical Research Institute – Rosenheck, 2014; Krausz et al., 2013; Martín-Santos et al., 2006). This dual diagnosis group of IMIM, Barcelona, Spain; Institut patients show poorer treatment outcomes, more clinical and social severity compared with de Neuropsiquiatria i addiccions patients with only one disorder, resulting in a high cost to the society (Krausz et al., 2013). – INAD, Barcelona, Spain; Redes Temáticas de Investigación Although SUD is more frequent among males than http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Dual Diagnosis Emerald Publishing

Loading next page...
 
/lp/emerald-publishing/psychiatric-co-morbidity-among-women-with-substance-use-disorders-BgPVwQKFSf
Publisher
Emerald Publishing
Copyright
Copyright © Emerald Group Publishing Limited
ISSN
1757-0972
DOI
10.1108/ADD-11-2017-0024
Publisher site
See Article on Publisher Site

Abstract

Guest editorial Alexandra Garcia-Guix, Juan Ignacio Mestre-Pinto, Judit Tirado-Muñoz, Antonia Domingo-Salvany and Marta Torrens Alexandra Garcia-Guix is based at the Hospital del Mar Medical Epidemiological and clinical studies have described a high co-occurrence of substance use Research Institute – IMIM, disorders (SUD) and other psychiatric disorders, known as “dual diagnosis” (Torrens et al., n.d.; Barcelona, Spain; and Institut de Kingston et al., 2017). These patients with a dual diagnosis are reported to have more Neuropsiquiatria i addiccions – INAD, Barcelona, Spain. emergency admissions, higher prevalence of suicide, increased rates of medical co-morbidity, Juan Ignacio Mestre-Pinto is more risk of relapse in drug use and psychiatric disorder, higher unemployment and based at the Hospital del Mar homelessness rates and greater incident of violent or criminal behaviour (Greenberg and Medical Research Institute – Rosenheck, 2014; Krausz et al., 2013; Martín-Santos et al., 2006). This dual diagnosis group of IMIM, Barcelona, Spain; Institut patients show poorer treatment outcomes, more clinical and social severity compared with de Neuropsiquiatria i addiccions patients with only one disorder, resulting in a high cost to the society (Krausz et al., 2013). – INAD, Barcelona, Spain; Redes Temáticas de Investigación Although SUD is more frequent among males than

Journal

Advances in Dual DiagnosisEmerald Publishing

Published: Feb 19, 2018

References